GGrantIndex
← Leaderboards

Michael D. Dennis

Pennsylvania State Univ Hershey Med Ctr

$5,943,850
Attributed
$5,943,850
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,943,850 · 6

By mechanism

R01$4,439,984 · 2
R00$736,470 · 1
R21$460,350 · 1
K99$170,156 · 1
F32$136,890 · 1

Top collaborators

No co-investigators on record.

Most similar at Pennsylvania State Univ Hershey Med Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusLaboratoriesMessenger RnaMediatingRetinaDiabeticPreventProteinsMolecularPlayDiabetic MouseBlindnessInnovative TherapyPathogenesisDiabetic RetinopathyGene ExpressionPathologyDesignFunctional DisorderPathway InteractionsResponseLeadProtein ExpressionEvent

Grant awards (22)

Redox-sensitive activation of REDD1 in diabetic retinopathy$461,273
R01 · FY2025 · EY · contact PI
Unifying Mechanism of Oxidative Stress and Inflammation in AMD$209,250
R21 · FY2025 · EY · contact PI
Redox-sensitive activation of REDD1 in diabetic retinopathy$543,314
R01 · FY2024 · EY · contact PI
Unifying Mechanism of Oxidative Stress and Inflammation in AMD$251,100
R21 · FY2024 · EY · contact PI
Redox-sensitive activation of REDD1 in diabetic retinopathy$472,818
R01 · FY2023 · EY · contact PI
Targeting the Etiology of Diabetic Retinopathy$377,764
R01 · FY2023 · EY · contact PI
Redox-sensitive activation of REDD1 in diabetic retinopathy$458,632
R01 · FY2022 · EY · contact PI
Targeting the Etiology of Diabetic Retinopathy$366,636
R01 · FY2022 · EY · contact PI
Redox-sensitive activation of REDD1 in diabetic retinopathy$472,818
R01 · FY2021 · EY · contact PI
Targeting the Etiology of Diabetic Retinopathy$366,833
R01 · FY2021 · EY · contact PI
Targeting the Etiology of Diabetic Retinopathy$82,723
R01 · FY2021 · EY · contact PI
Targeting the Etiology of Diabetic Retinopathy$80,241
R01 · FY2021 · EY · contact PI
Targeting the Etiology of Diabetic Retinopathy$378,372
R01 · FY2020 · EY · contact PI
Targeting the Etiology of Diabetic Retinopathy$378,560
R01 · FY2019 · EY · contact PI
Hyperglycemia-induced translational control of gene expression in the retina$241,956
R00 · FY2017 · EY · contact PI
Hyperglycemia-induced translational control of gene expression in the retina$245,514
R00 · FY2016 · EY · contact PI
Hyperglycemia-induced translational control of gene expression in the retina$249,000
R00 · FY2015 · EY · contact PI
Hyperglycemia-induced translational control of gene expression in the retina$85,078
K99 · FY2014 · EY · contact PI
Hyperglycemia-induced translational control of gene expression in the retina$85,078
K99 · FY2013 · EY · contact PI
Effects of diet and diabetes on gene expression in the liver$32,474
F32 · FY2013 · DK · contact PI
Effects of diet and diabetes on gene expression in the liver$53,942
F32 · FY2012 · DK · contact PI
Effects of diet and diabetes on gene expression in the liver$50,474
F32 · FY2010 · DK · contact PI